Coya Therapeutics (COYA) Cash from Operations (2022 - 2026)

Coya Therapeutics (COYA) has 5 years of Cash from Operations data on file, last reported at 6208530.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 119.52% year-over-year to 6208530.0; the trailing twelve-month figure through Mar 2026 stood at 14119556.0 (up 7.49% YoY), and the FY2025 full-year result was 10739301.0, down 4.38% from the prior year.
• Cash from Operations declined to 6208530.0 in Q1 2026, from 1007127.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 2145874.0 in Q1 2024 to a low of 6208530.0 in Q1 2026.
• A 5-year average of 2686165.76 and a median of 2241080.0 in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations surged 155.54% in 2024 and plunged 231.8% in 2025, its largest moves.
• Tracing COYA's Cash from Operations over 5 years: stood at 2223075.0 in 2022, then declined by 0.81% to 2241080.0 in 2023, then slipped by 7.53% to 2409767.0 in 2024, then surged by 58.21% to 1007127.0 in 2025, then slumped by 516.46% to 6208530.0 in 2026.
• Business Quant data shows COYA's Cash from Operations at 6208530.0 in Q1 2026, 1007127.0 in Q4 2025, and 1130603.0 in Q3 2025.